Average Co-Inventor Count = 11.24
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (11 from 2,076 patents)
2. Janssen Biotech, Inc. (3 from 410 patents)
3. Janssen Sciences Ireland Unlimited Company (1 from 60 patents)
15 patents:
1. 12162951 - Anti-idiotypic antibodies against anti-KLK2 antibodies
2. 12134636 - Immunoglobulins and uses thereof
3. 12030937 - Anti-idiotypic antibodies against anti-GPRC5D antibodies
4. 11780900 - Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
5. 11767354 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
6. 11591379 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
7. 11401315 - Immunoglobulins and uses thereof
8. 11236155 - Antibodies to pyroglutamate amyloid-β and uses thereof
9. 10968265 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
10. 10875902 - Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
11. 10858413 - Immunoglobulins and uses thereof
12. 10787495 - Immunoglobulins and uses thereof
13. 10640544 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
14. 10428134 - Immunoglobulins and uses thereof
15. 10179808 - Kv1.3 antagonists and methods of use